Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-a
about
Maraviroc: a review of its use in HIV infection and beyondDisturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric SymptomsThe Chronicity of HIV Infection Should Drive the Research Strategy of NeuroHIV Treatment Studies: A Critical ReviewHIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective.Neurological Response to cART vs. cART plus Integrase Inhibitor and CCR5 Antagonist Initiated during Acute HIVLoss of CCR2 expressing non-classical monocytes are associated with cognitive impairment in antiretroviral therapy-naïve HIV-infected Thais.Non-classical monocytes predict progression of carotid artery bifurcation intima-media thickness in HIV-infected individuals on stable antiretroviral therapyStrategies to target non-T-cell HIV reservoirsMaraviroc Intensification Improves Endothelial Function in Abacavir-Treated Patients, an Open-Label Randomized Cross-Over Pilot StudyCCR5 is a suppressor for cortical plasticity and hippocampal learning and memory.CCR5 blockade for neuroinflammatory diseases--beyond control of HIV.Neurologic Complications in Treated HIV-1 Infection.Cognitive Impairment and Persistent CNS Injury in Treated HIV.Treating HIV Infection in the Central Nervous System.Neurocognition with maraviroc compared with tenofovir in HIV.Central nervous system-penetrating antiretrovirals impair energetic reserve in striatal nerve terminals.Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders.Off-label use of maraviroc in clinical practice.Neuropsychological performance in African children with HIV enrolled in a multisite antiretroviral clinical trial.CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON study.Alterations of expression of inflammation/immune-related genes in the dorsal and ventral striatum of adult C57BL/6J mice following chronic oxycodone self-administration: a RNA sequencing study.The Biology of Monocytes and Dendritic Cells: Contribution to HIV Pathogenesis.Global HIV neurology: a comprehensive review.
P2860
Q26778504-A2DA58F0-35A0-4BB8-B3F4-9A4F58F06DF0Q26800052-34F74363-5D48-4A83-B4A6-CA32076AA1B0Q28066725-12FEB73B-63EB-4185-97BE-349E4DB99FDEQ35698144-0A768DB4-B183-435C-B829-9752EE197B45Q35837184-FE1D9D5B-EFC9-4C03-9EB8-4D3AAE826D21Q36250020-48564E0E-95D1-4EF3-8ADA-2B258BFC0376Q36966437-7C087FAF-1E15-429D-9EEB-A8F19F1E58B2Q37099969-48C8582C-D40A-4EF0-AF35-529C8C4B6BBDQ37250180-D635E64C-B452-433B-B546-E8F701E8F2F9Q37557899-C0992246-A244-4889-A291-4BC348F1AAB7Q38702121-433BC3B1-AA35-41D2-B354-044E2A815CF8Q38832560-43A599F7-2FDF-4C0C-86D1-49E08FCA97AAQ38836472-57BCFA88-09C8-4C7B-AB1C-EDFE53097EBFQ39077816-780A7486-06CF-4522-ABE8-9EE87506B74FQ39402373-912C1C72-4F1A-4638-AED2-A6FE1037E4C7Q40051820-95DF444B-A92A-4D4B-A8A3-EAFF3012F20DQ40738275-A1188220-C9E5-4459-927A-AFDCE72FDFCBQ42654565-BC05933F-B2B0-4EE9-9A26-0EC64EA8F6CBQ46866659-9A992033-93AD-4E78-8F6A-DCDE7A7F9628Q47894419-9BBB1A38-889F-495F-B862-C2EFB715B2C5Q48222965-94086DC6-B467-4917-A0E8-633253C11BC1Q50131761-E1CF2BFF-83E6-41CB-9749-802AC79D372FQ51762497-6C5D10F5-AA67-4D9C-984E-5789ABCCF743
P2860
Treatment intensification with maraviroc (CCR5 antagonist) leads to declines in CD16-expressing monocytes in cART-suppressed chronic HIV-infected subjects and is associated with improvements in neurocognitive test performance: implications for HIV-a
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Treatment intensification with ...... rmance: implications for HIV-a
@ast
Treatment intensification with ...... rmance: implications for HIV-a
@en
Treatment intensification with maraviroc
@nl
type
label
Treatment intensification with ...... rmance: implications for HIV-a
@ast
Treatment intensification with ...... rmance: implications for HIV-a
@en
Treatment intensification with maraviroc
@nl
prefLabel
Treatment intensification with ...... rmance: implications for HIV-a
@ast
Treatment intensification with ...... rmance: implications for HIV-a
@en
Treatment intensification with maraviroc
@nl
P2093
P2860
P1476
Treatment intensification with ...... neurocognitive disease (HAND)
@en
P2093
Beau Nakamoto
Bruce T Shiramizu
Cecilia M Shikuma
Dominic C Chow
Glen M Chew
Guangxiang Zhang
Kalpana J Kallianpur
Melissa Agsalda
Nancy Hanks
P2860
P2888
P304
P356
10.1007/S13365-014-0279-X
P50
P577
2014-09-17T00:00:00Z